TONIX PHARMACEUTICALS HOLDING CORP. (NASDAQ:TNXP) Files An 8-K Other Events
Item 8.01
On December 3, 2019, Tonix Pharmaceuticals Holding Corp. (the “Company”) issued a press release announcing that on December 2, 2019, the Company received a letter from The NASDAQ Stock Market LLC (“NASDAQ”) stating that because the Company’s shares had a closing bid price at or above $1.00 per share for a minimum of ten consecutive business days, the Company’s stock had regained compliance with the minimum bid price requirement of $1.00 per share for continued listing on the NASDAQ Global Market, as set forth in NASDAQ Listing Rule 5450(a)(1), and that the matter is now closed. A copy of the press release that discusses this matter is filed as Exhibit 99.01 to, and incorporated by reference in, this report.
| 99.01 | Press Release dated December 3, 2019, issued by the Company |
Tonix Pharmaceuticals Holding Corp. Exhibit
EX-99.01 2 ex99-01.htm PRESS RELEASE TONIX PHARMACEUTICALS HOLDING CORP. 8-K Exhibit 99.01 Tonix Pharmaceuticals Regains Compliance with NASDAQ Minimum Bid Price Requirement NEW YORK,…
To view the full exhibit click here
